The potential opposing roles of Akt1 and Akt2 in lung tumorigenesis suggest that development of non-selective Akt inhibitors may not be beneficial and in fact, may be detrimental, particularly in the case of lung cancer in never smokers. This evidence concerns the gene AKT2 and lung carcinoma.